Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence Article Swipe
Slaven Pikija
,
L. Sztriha
,
Johannes Sebastian Mutzenbach
,
Stefan Golaszewski
,
Johann Sellner
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1007/s40263-017-0460-x
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1007/s40263-017-0460-x
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1007/s40263-017-0460-x
- https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdf
- OA Status
- hybrid
- Cited By
- 43
- References
- 44
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2748331635
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2748331635Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s40263-017-0460-xDigital Object Identifier
- Title
-
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available EvidenceWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-08-14Full publication date if available
- Authors
-
Slaven Pikija, L. Sztriha, Johannes Sebastian Mutzenbach, Stefan Golaszewski, Johann SellnerList of authors in order
- Landing page
-
https://doi.org/10.1007/s40263-017-0460-xPublisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdfDirect OA link when available
- Concepts
-
Idarucizumab, Dabigatran, Medicine, Neurology, Stroke (engine), Ischemic stroke, Intensive care medicine, Anesthesia, Internal medicine, Ischemia, Psychiatry, Atrial fibrillation, Warfarin, Mechanical engineering, EngineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
43Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 2, 2023: 2, 2022: 3, 2021: 8, 2020: 8Per-year citation counts (last 5 years)
- References (count)
-
44Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2748331635 |
|---|---|
| doi | https://doi.org/10.1007/s40263-017-0460-x |
| ids.doi | https://doi.org/10.1007/s40263-017-0460-x |
| ids.mag | 2748331635 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28808918 |
| ids.openalex | https://openalex.org/W2748331635 |
| fwci | 6.03827175 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D061605 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Administration, Intravenous |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000368 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Aged |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000369 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Aged, 80 and over |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D061067 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[5].qualifier_ui | Q000008 |
| mesh[5].descriptor_ui | D000991 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | administration & dosage |
| mesh[5].descriptor_name | Antithrombins |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D000991 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Antithrombins |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D002545 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Brain Ischemia |
| mesh[8].qualifier_ui | Q000008 |
| mesh[8].descriptor_ui | D000069604 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | administration & dosage |
| mesh[8].descriptor_name | Dabigatran |
| mesh[9].qualifier_ui | Q000009 |
| mesh[9].descriptor_ui | D000069604 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | adverse effects |
| mesh[9].descriptor_name | Dabigatran |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D005260 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Female |
| mesh[11].qualifier_ui | Q000139 |
| mesh[11].descriptor_ui | D006470 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | chemically induced |
| mesh[11].descriptor_name | Hemorrhage |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008297 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Male |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D017410 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Practice Guidelines as Topic |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D020521 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Stroke |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D010959 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Tissue Plasminogen Activator |
| mesh[17].qualifier_ui | Q000009 |
| mesh[17].descriptor_ui | D010959 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | adverse effects |
| mesh[17].descriptor_name | Tissue Plasminogen Activator |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D061605 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Administration, Intravenous |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000368 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Aged |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000369 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Aged, 80 and over |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000818 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Animals |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D061067 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[23].qualifier_ui | Q000008 |
| mesh[23].descriptor_ui | D000991 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | administration & dosage |
| mesh[23].descriptor_name | Antithrombins |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D000991 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | Antithrombins |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D002545 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Brain Ischemia |
| mesh[26].qualifier_ui | Q000008 |
| mesh[26].descriptor_ui | D000069604 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | administration & dosage |
| mesh[26].descriptor_name | Dabigatran |
| mesh[27].qualifier_ui | Q000009 |
| mesh[27].descriptor_ui | D000069604 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | adverse effects |
| mesh[27].descriptor_name | Dabigatran |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | Q000139 |
| mesh[29].descriptor_ui | D006470 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | chemically induced |
| mesh[29].descriptor_name | Hemorrhage |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008297 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Male |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D017410 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Practice Guidelines as Topic |
| mesh[33].qualifier_ui | Q000188 |
| mesh[33].descriptor_ui | D020521 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | drug therapy |
| mesh[33].descriptor_name | Stroke |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D010959 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | Tissue Plasminogen Activator |
| mesh[35].qualifier_ui | Q000009 |
| mesh[35].descriptor_ui | D010959 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | adverse effects |
| mesh[35].descriptor_name | Tissue Plasminogen Activator |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D061605 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Administration, Intravenous |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000368 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Aged |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D000369 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Aged, 80 and over |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000818 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Animals |
| mesh[40].qualifier_ui | Q000627 |
| mesh[40].descriptor_ui | D061067 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | therapeutic use |
| mesh[40].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[41].qualifier_ui | Q000008 |
| mesh[41].descriptor_ui | D000991 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | administration & dosage |
| mesh[41].descriptor_name | Antithrombins |
| mesh[42].qualifier_ui | Q000009 |
| mesh[42].descriptor_ui | D000991 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | adverse effects |
| mesh[42].descriptor_name | Antithrombins |
| mesh[43].qualifier_ui | Q000188 |
| mesh[43].descriptor_ui | D002545 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | drug therapy |
| mesh[43].descriptor_name | Brain Ischemia |
| mesh[44].qualifier_ui | Q000008 |
| mesh[44].descriptor_ui | D000069604 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | administration & dosage |
| mesh[44].descriptor_name | Dabigatran |
| mesh[45].qualifier_ui | Q000009 |
| mesh[45].descriptor_ui | D000069604 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | adverse effects |
| mesh[45].descriptor_name | Dabigatran |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D005260 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Female |
| mesh[47].qualifier_ui | Q000139 |
| mesh[47].descriptor_ui | D006470 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | chemically induced |
| mesh[47].descriptor_name | Hemorrhage |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D008297 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Male |
| type | review |
| title | Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence |
| biblio.issue | 9 |
| biblio.volume | 31 |
| biblio.last_page | 757 |
| biblio.first_page | 747 |
| topics[0].id | https://openalex.org/T10065 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Atrial Fibrillation Management and Outcomes |
| topics[1].id | https://openalex.org/T11064 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9980000257492065 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Antiplatelet Therapy and Cardiovascular Diseases |
| topics[2].id | https://openalex.org/T10227 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9977999925613403 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Acute Ischemic Stroke Management |
| funders[0].id | https://openalex.org/F4320327318 |
| funders[0].ror | https://ror.org/03z3mg085 |
| funders[0].display_name | Paracelsus Medizinische Privatuniversität |
| is_xpac | False |
| apc_list.value | 3390 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4390 |
| apc_paid.value | 3390 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4390 |
| concepts[0].id | https://openalex.org/C2776413415 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9025794267654419 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q17630273 |
| concepts[0].display_name | Idarucizumab |
| concepts[1].id | https://openalex.org/C2778810321 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8796825408935547 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q419345 |
| concepts[1].display_name | Dabigatran |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.8015408515930176 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C16568411 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6124852895736694 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q83042 |
| concepts[3].display_name | Neurology |
| concepts[4].id | https://openalex.org/C2780645631 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5882591009140015 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q671554 |
| concepts[4].display_name | Stroke (engine) |
| concepts[5].id | https://openalex.org/C3020199598 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5151711702346802 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q12202 |
| concepts[5].display_name | Ischemic stroke |
| concepts[6].id | https://openalex.org/C177713679 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4492914080619812 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[6].display_name | Intensive care medicine |
| concepts[7].id | https://openalex.org/C42219234 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4103237986564636 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q131130 |
| concepts[7].display_name | Anesthesia |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.2288757860660553 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C541997718 |
| concepts[9].level | 2 |
| concepts[9].score | 0.1454707682132721 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q188151 |
| concepts[9].display_name | Ischemia |
| concepts[10].id | https://openalex.org/C118552586 |
| concepts[10].level | 1 |
| concepts[10].score | 0.11532509326934814 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[10].display_name | Psychiatry |
| concepts[11].id | https://openalex.org/C2779161974 |
| concepts[11].level | 2 |
| concepts[11].score | 0.11376559734344482 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q815819 |
| concepts[11].display_name | Atrial fibrillation |
| concepts[12].id | https://openalex.org/C2776301958 |
| concepts[12].level | 3 |
| concepts[12].score | 0.10171213746070862 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q407431 |
| concepts[12].display_name | Warfarin |
| concepts[13].id | https://openalex.org/C78519656 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101333 |
| concepts[13].display_name | Mechanical engineering |
| concepts[14].id | https://openalex.org/C127413603 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[14].display_name | Engineering |
| keywords[0].id | https://openalex.org/keywords/idarucizumab |
| keywords[0].score | 0.9025794267654419 |
| keywords[0].display_name | Idarucizumab |
| keywords[1].id | https://openalex.org/keywords/dabigatran |
| keywords[1].score | 0.8796825408935547 |
| keywords[1].display_name | Dabigatran |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.8015408515930176 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/neurology |
| keywords[3].score | 0.6124852895736694 |
| keywords[3].display_name | Neurology |
| keywords[4].id | https://openalex.org/keywords/stroke |
| keywords[4].score | 0.5882591009140015 |
| keywords[4].display_name | Stroke (engine) |
| keywords[5].id | https://openalex.org/keywords/ischemic-stroke |
| keywords[5].score | 0.5151711702346802 |
| keywords[5].display_name | Ischemic stroke |
| keywords[6].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[6].score | 0.4492914080619812 |
| keywords[6].display_name | Intensive care medicine |
| keywords[7].id | https://openalex.org/keywords/anesthesia |
| keywords[7].score | 0.4103237986564636 |
| keywords[7].display_name | Anesthesia |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.2288757860660553 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/ischemia |
| keywords[9].score | 0.1454707682132721 |
| keywords[9].display_name | Ischemia |
| keywords[10].id | https://openalex.org/keywords/psychiatry |
| keywords[10].score | 0.11532509326934814 |
| keywords[10].display_name | Psychiatry |
| keywords[11].id | https://openalex.org/keywords/atrial-fibrillation |
| keywords[11].score | 0.11376559734344482 |
| keywords[11].display_name | Atrial fibrillation |
| keywords[12].id | https://openalex.org/keywords/warfarin |
| keywords[12].score | 0.10171213746070862 |
| keywords[12].display_name | Warfarin |
| language | en |
| locations[0].id | doi:10.1007/s40263-017-0460-x |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S153913659 |
| locations[0].source.issn | 1172-7047, 1179-1934 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1172-7047 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | CNS Drugs |
| locations[0].source.host_organization | https://openalex.org/P4310320330 |
| locations[0].source.host_organization_name | Adis, Springer Healthcare |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320330 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | CNS Drugs |
| locations[0].landing_page_url | https://doi.org/10.1007/s40263-017-0460-x |
| locations[1].id | pmid:28808918 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | CNS drugs |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28808918 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:5573762 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | CNS Drugs |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5573762 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5077499297 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6070-3635 |
| authorships[0].author.display_name | Slaven Pikija |
| authorships[0].countries | AT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I27945538, https://openalex.org/I4210106988 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[0].institutions[0].id | https://openalex.org/I4210106988 |
| authorships[0].institutions[0].ror | https://ror.org/01fpkt395 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210106988 |
| authorships[0].institutions[0].country_code | AT |
| authorships[0].institutions[0].display_name | Christian Doppler Klinik |
| authorships[0].institutions[1].id | https://openalex.org/I27945538 |
| authorships[0].institutions[1].ror | https://ror.org/03z3mg085 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I27945538 |
| authorships[0].institutions[1].country_code | AT |
| authorships[0].institutions[1].display_name | Paracelsus Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Slaven Pikija |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[1].author.id | https://openalex.org/A5030327357 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4639-3180 |
| authorships[1].author.display_name | L. Sztriha |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210153400 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Neurology, King's College Hospital, Denmark Hill, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I4210153400 |
| authorships[1].institutions[0].ror | https://ror.org/044nptt90 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210111135, https://openalex.org/I4210153400 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | King's College Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Laszlo K. Sztriha |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Neurology, King's College Hospital, Denmark Hill, London, UK |
| authorships[2].author.id | https://openalex.org/A5013506358 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Johannes Sebastian Mutzenbach |
| authorships[2].countries | AT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I27945538, https://openalex.org/I4210106988 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[2].institutions[0].id | https://openalex.org/I4210106988 |
| authorships[2].institutions[0].ror | https://ror.org/01fpkt395 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210106988 |
| authorships[2].institutions[0].country_code | AT |
| authorships[2].institutions[0].display_name | Christian Doppler Klinik |
| authorships[2].institutions[1].id | https://openalex.org/I27945538 |
| authorships[2].institutions[1].ror | https://ror.org/03z3mg085 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I27945538 |
| authorships[2].institutions[1].country_code | AT |
| authorships[2].institutions[1].display_name | Paracelsus Medical University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | J. Sebastian Mutzenbach |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[3].author.id | https://openalex.org/A5086407082 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2055-0072 |
| authorships[3].author.display_name | Stefan Golaszewski |
| authorships[3].countries | AT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I27945538, https://openalex.org/I4210106988 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[3].institutions[0].id | https://openalex.org/I4210106988 |
| authorships[3].institutions[0].ror | https://ror.org/01fpkt395 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210106988 |
| authorships[3].institutions[0].country_code | AT |
| authorships[3].institutions[0].display_name | Christian Doppler Klinik |
| authorships[3].institutions[1].id | https://openalex.org/I27945538 |
| authorships[3].institutions[1].ror | https://ror.org/03z3mg085 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I27945538 |
| authorships[3].institutions[1].country_code | AT |
| authorships[3].institutions[1].display_name | Paracelsus Medical University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Stefan M. Golaszewski |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Austria |
| authorships[4].author.id | https://openalex.org/A5053256015 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8749-5533 |
| authorships[4].author.display_name | Johann Sellner |
| authorships[4].countries | DE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2802619606, https://openalex.org/I62916508 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany |
| authorships[4].institutions[0].id | https://openalex.org/I2802619606 |
| authorships[4].institutions[0].ror | https://ror.org/04jc43x05 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2802619606, https://openalex.org/I62916508 |
| authorships[4].institutions[0].country_code | DE |
| authorships[4].institutions[0].display_name | Klinikum rechts der Isar |
| authorships[4].institutions[1].id | https://openalex.org/I62916508 |
| authorships[4].institutions[1].ror | https://ror.org/02kkvpp62 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I62916508 |
| authorships[4].institutions[1].country_code | DE |
| authorships[4].institutions[1].display_name | Technical University of Munich |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Johann Sellner |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10065 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Atrial Fibrillation Management and Outcomes |
| related_works | https://openalex.org/W2464106697, https://openalex.org/W2215752318, https://openalex.org/W2216476530, https://openalex.org/W2467166492, https://openalex.org/W2548615347, https://openalex.org/W2625842675, https://openalex.org/W2106760090, https://openalex.org/W2765260309, https://openalex.org/W2763237434, https://openalex.org/W2207692988 |
| cited_by_count | 43 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 3 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 8 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 8 |
| counts_by_year[5].year | 2019 |
| counts_by_year[5].cited_by_count | 6 |
| counts_by_year[6].year | 2018 |
| counts_by_year[6].cited_by_count | 13 |
| counts_by_year[7].year | 2017 |
| counts_by_year[7].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s40263-017-0460-x |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S153913659 |
| best_oa_location.source.issn | 1172-7047, 1179-1934 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1172-7047 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | CNS Drugs |
| best_oa_location.source.host_organization | https://openalex.org/P4310320330 |
| best_oa_location.source.host_organization_name | Adis, Springer Healthcare |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | CNS Drugs |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s40263-017-0460-x |
| primary_location.id | doi:10.1007/s40263-017-0460-x |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S153913659 |
| primary_location.source.issn | 1172-7047, 1179-1934 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1172-7047 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | CNS Drugs |
| primary_location.source.host_organization | https://openalex.org/P4310320330 |
| primary_location.source.host_organization_name | Adis, Springer Healthcare |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007%2Fs40263-017-0460-x.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | CNS Drugs |
| primary_location.landing_page_url | https://doi.org/10.1007/s40263-017-0460-x |
| publication_date | 2017-08-14 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2530008157, https://openalex.org/W2510777240, https://openalex.org/W2136489990, https://openalex.org/W2097854437, https://openalex.org/W2162508946, https://openalex.org/W2096246254, https://openalex.org/W2060633440, https://openalex.org/W2885288119, https://openalex.org/W2524925871, https://openalex.org/W2113132111, https://openalex.org/W2192043826, https://openalex.org/W2023917690, https://openalex.org/W2129241155, https://openalex.org/W2041263654, https://openalex.org/W2042636441, https://openalex.org/W2126850212, https://openalex.org/W2015751459, https://openalex.org/W1513839038, https://openalex.org/W2476063068, https://openalex.org/W2088083930, https://openalex.org/W4250104750, https://openalex.org/W2424864893, https://openalex.org/W2520409079, https://openalex.org/W2408353228, https://openalex.org/W2462201328, https://openalex.org/W2520065759, https://openalex.org/W2587171757, https://openalex.org/W2588232709, https://openalex.org/W2581898303, https://openalex.org/W2588924529, https://openalex.org/W2601600299, https://openalex.org/W2592468674, https://openalex.org/W2610221038, https://openalex.org/W2607361343, https://openalex.org/W2600746606, https://openalex.org/W2527423766, https://openalex.org/W2268423685, https://openalex.org/W2113446992, https://openalex.org/W2064696767, https://openalex.org/W2082543806, https://openalex.org/W2123217665, https://openalex.org/W2468230121, https://openalex.org/W1641613989, https://openalex.org/W2513214530 |
| referenced_works_count | 44 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5053256015 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I2802619606, https://openalex.org/I62916508 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.96402359 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |